Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis

Journal article

Peer reviewed

A. Nayak, Thomas B. Casale, SD Miller, J. Condemi, M. McAlary, A. Fowler-Taylor, G. Della Cioppa and N. Gupta

Allergy and Asthma Proceedings, Vol.24(5), pp.323-329

09/2003

PMID: 14619332

Metrics

5 Record Views

Title: Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis
Creators: A. Nayak (Author)
Thomas B. Casale (Author) - Creighton University
SD Miller (Author)
J. Condemi (Author)
M. McAlary (Author)
A. Fowler-Taylor (Author)
G. Della Cioppa (Author)
N. Gupta (Author)
Publication Details: Allergy and Asthma Proceedings, Vol.24(5), pp.323-329
Number of pages: 323-329
Identifiers: 991005932663602656
Academic Unit: School of Medicine; Allergy-Immunology
Resource Type: Journal article